Summary of Significant Accounting Policies - Additional Information (Details) |
3 Months Ended | ||
|---|---|---|---|
|
Mar. 31, 2026
USD ($)
asset_group
reportingUnit
|
Mar. 31, 2025
USD ($)
|
Dec. 31, 2025
USD ($)
|
|
| Disaggregation of Revenue [Line Items] | |||
| Receivables, net | $ 149,620,000 | $ 32,149,000 | |
| Number of reporting unit | reportingUnit | 1 | ||
| Goodwill, acquired during period | $ 68,480,000 | ||
| Goodwill impairment | 0 | $ 0 | |
| Impairment expense | $ 0 | $ 0 | |
| Number of asset groups | asset_group | 3 | ||
| Deferred revenue | $ 165,132,000 | $ 127,160,000 | |
| Deferred revenue, increase | 38,000,000.0 | ||
| Manufacturer's Discount And Rebate Receivable | |||
| Disaggregation of Revenue [Line Items] | |||
| Receivables, net | 131,500,000 | ||
| YourBio Health, Inc. | |||
| Disaggregation of Revenue [Line Items] | |||
| Goodwill, acquired during period | $ 69,500,000 | ||
| X | ||||||||||
- Definition Contract With Customer, Liability, Period Increase (Decrease) No definition available.
|
| X | ||||||||||
- Definition Number Of Asset Groups No definition available.
|
| X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment. No definition available.
|
| X | ||||||||||
- Definition The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|